Ivermectin Reproposing for Mild Stage COVID-19 Outpatients

NCT04784481 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

254

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid19
SARS (Severe Acute Respiratory Syndrome)

Interventions

DRUG: Ivermectin

Sponsor

Ministry of Public Health, Argentina